Genky DrugStores Co., Ltd.

9267

JP3282750003

Drug Retailers

Delayed Japan Exchange Other stock markets 10:41:58 07/06/2024 am IST			5-day change	1st Jan Change
5,870 ^JPY	+1.38%		+3.53%	+7.51%

03/06	Genky Drugstores' All Stores Sales Up 6.9% on Year	MT
30/04	Genky Drugstores Co., Ltd. Reports Sales Results for the Month and Third Quarter Ended April 2024	CI

Genky DrugStores Co., Ltd.'s Equity Buyback announced on April 19, 2019 has closed with 300,000 shares for ¥788.24 million.

May 31, 2019

The company closed its plan on May 31, 2019.

Latest news about Genky DrugStores Co., Ltd.

Genky Drugstores' All Stores Sales Up 6.9% on Year	03/06	MT
Genky Drugstores Co., Ltd. Reports Sales Results for the Month and Third Quarter Ended April 2024	30/04	CI
Genky Drugstores Co., Ltd. Provides Dividend Guidance for the Fiscal Year 2023	25/04	CI
Genky Drugstores Co., Ltd. Announces Dividend for the Second Quarter for the Fiscal Year 2023	25/04	CI
Genky Drugstores Co., Ltd. Reports Sales Results for the Month and Third Quarter Ended March 2024	29/03	CI
Genky DrugStores Co., Ltd. Provides Dividend Guidance for Year Ending June 20, 2024	29/01	CI
Genky DrugStores Co., Ltd. Provides Consolidated Earnings Guidance for the Fiscal Year Ending June 20, 2024	29/01	CI
Genky Drugstores Co., Ltd. Provides Dividend Guidance for Second Quarter and Full Year of Year Ending June 20, 2024	30/23/30	CI
Genky DrugStores’s Attributable Net Income Up 7.8% to 4.76 Billion Yen in Fiscal 2022; Shares Rise 8%	25/23/25	MT
Genky Drugstores Co., Ltd. Announces Dividend for the Year Ended June 20, 2023, Payable on September 8, 2023; Provides Dividend Guidance for Second Quarter and Full Year of Year Ending June 20, 2024	24/23/24	CI
Genky Drugstores Co., Ltd. Provides Consolidated Earnings Guidance for the First Half and Full Year of Fiscal Year Ending June 20, 2024	24/23/24	CI
Genky DrugStores Co., Ltd. Provides Year-End Dividend Guidance for the Fiscal Year Ending June 20, 2023	24/23/24	CI
Genky DrugStores Co., Ltd. Provides Consolidated Earnings Guidance for the Fiscal Year Ending June 20, 2023	24/23/24	CI
Genky DrugStores Co., Ltd. Provides Consolidated Earnings Guidance for the Fiscal Year Ending June 20, 2023	31/23/31	CI
Genky DrugStores Co., Ltd. Announces Dividend for the Second Quarter Ended December 20, 2022, Payable on February 27, 2023; Provides Dividend Guidance for the Fiscal Year Ending June 20, 2023	31/23/31	CI
Genky DrugStores Co., Ltd. Provides Consolidated Earnings Guidance for the First Half of Fiscal Year Ending June 20, 2023 and Full Year Ending June 20, 2023	24/22/24	CI
Genky DrugStores Co., Ltd. Provides Second Quarter End and Year End Dividend Guidance for the Fiscal 2022	24/22/24	CI
Genky Drugstores Co., Ltd. Provides Consolidated Earnings Guidance for the First Half and Full Year of Fiscal Year Ending June 20, 2023	26/22/26	CI
Genky DrugStores Co., Ltd. Provides Dividend Guidance for the Fiscal 2021	28/22/28	CI
Genky Drugstores Co., Ltd. Provides Consolidated Earnings Guidance for the Fiscal Year Ending June 20, 2022	28/22/28	CI
Genky Drugstores Co., Ltd. Provides Earnings Guidance for the Fiscal Year Ending June 30, 2022	25/22/25	CI
Genky DrugStores Co., Ltd. Provides Consolidated Earnings Guidance for the First Half and Full Year Ending June 30, 2022	27/21/27	CI
Genky Drugstores Co., Ltd. Provides Dividend Guidance for the Second Quarter of Fiscal Year Ending June 20, 2022 and Full Year Ending June 20, 2022	27/21/27	CI
Genky Drugstores Co., Ltd. Reports Consolidated and Non-Consolidated Earnings Results for the Year Ended June 20, 2021	27/21/27	CI
Genky DrugStores Co., Ltd. Provides Consolidated Earnings Guidance for the First Half and Fiscal Year June 20, 2022	27/21/27	CI

Chart Genky DrugStores Co., Ltd.

Duration

Period

More charts

Genky DrugStores Co Ltd is mainly engaged in the management of group companies and the related business. The Company is mainly engaged in the retail of medicines, cosmetics, miscellaneous goods, foods and others.

Sector

Drug Retailers

Calendar

23/07/2024 - Q4 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Ratings for Genky DrugStores Co., Ltd.

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

5,790 JPY

Average target price

7,600 JPY

Spread / Average Target

+31.26%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Drug Retailers

	1st Jan change	Capi.
GENKY DRUGSTORES CO., LTD.	+7.51%	564M
JD HEALTH INTERNATIONAL INC.	-33.89%	10.84B
ALIBABA HEALTH INFORMATION TECHNOLOGY LIMITED	-9.43%	7.78B
YIFENG PHARMACY CHAIN CO., LTD.	+9.89%	6.14B
MATSUKIYOCOCOKARA & CO.	-14.36%	5.9B
CORPORATIVO FRAGUA, S.A.B. DE C.V.	+74.92%	4.79B
NAHDI MEDICAL COMPANY	-4.09%	4.55B
CLICKS GROUP LIMITED	-7.88%	3.77B
DASHENLIN PHARMACEUTICAL GROUP CO., LTD.	-20.92%	3.1B
WELCIA HOLDINGS CO., LTD.	-13.67%	2.81B

Other Drug Retailers

Genky DrugStores Co., Ltd.

Equities

9267

JP3282750003

Drug Retailers

Genky DrugStores Co., Ltd.'s Equity Buyback announced on April 19, 2019 has closed with 300,000 shares for ¥788.24 million.

Latest news about Genky DrugStores Co., Ltd.

Chart Genky DrugStores Co., Ltd.

Company Profile

Income Statement Evolution

Ratings for Genky DrugStores Co., Ltd.

Analysts' Consensus

EPS Revisions

Quarterly earnings - Rate of surprise

Sector Other Drug Retailers